This page collects WhisperX intelligence signals tagged #Compounding Pharmacies. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
The U.S. Food and Drug Administration (FDA) is reportedly preparing to grant compounding pharmacies the authority to produce and dispense injectable peptide drugs. This potential policy shift represents a significant regulatory development for a class of substances that has surged in popularity for uses ranging from we...
The U.S. Food and Drug Administration is preparing to reverse a significant safety policy, moving to potentially allow compounding pharmacies to produce more than a dozen injectable peptides it had previously banned. These substances, removed from the approved compounding list in 2023, were flagged for 'potentially sig...
The FDA is convening a critical advisory panel to reconsider its crackdown on compounded peptides, a move that follows direct public advocacy from presidential candidate Robert F. Kennedy Jr. The July 23-24 meeting will specifically debate whether to add seven peptides back to an approved list for compounding pharmacie...